Issue Cover & Information

Free Access

Issue Information

  • Pages: 2547-2549
  • First Published: 21 August 2017
Issue Information Issue 16, 2017

Here, an Anopheles stephensi mosquito is obtaining a blood meal from a human host through its pointed proboscis. Image credit: Centers for Disease Control and Prevention / Dr. William Collins.

Introduction

Free Access

Introduction to the Special Issue on Malaria

  • Pages: 2550-2552
  • First Published: 21 August 2017
Introduction to the Special Issue on Malaria Issue 16, 2017

This minireview series highlights recent developments in malaria research. The reviews cover diverse topics, from conventional antimalarial therapies and the strategies used to circumvent the emergence of drug resistance, to the latest approaches for the discovery and validation of new druggable targets and for the development of effective antimalarial vaccines.

Commentaries

Free Access

Malaria, metabolism and mathematical models

  • Pages: 2553-2555
  • First Published: 21 August 2017
Malaria, metabolism and mathematical models Issue 16, 2017

Understanding the dynamic behaviour of the Plasmodium falciparum metabolism during infection can help identify targets for drug development. In this Commentary, we highlight recently published studies in The FEBS Journal that cover mathematical modelling of glycolysis in P. falciparum and the identification and in vivo validation of metabolic drug targets.

Free Access

Recent buzz in malaria research

  • Pages: 2556-2559
  • First Published: 21 August 2017
Recent buzz in malaria research Issue 16, 2017

In this Commentary, we highlight the latest findings in three active areas of malaria research: Plasmodium biology; host response; and malaria control, prevention and treatment.

Review Articles

Free Access

Vaccines against malaria—still a long way to go

  • Pages: 2560-2568
  • First Published: 13 May 2017
Vaccines against malaria—still a long way to go Issue 16, 2017

Malaria is caused by Plasmodium parasites and remains the most important mosquito-borne infectious disease. In this review, recent opportunities and persistent challenges for evidence-based malaria vaccine design are discussed. A better understanding of Plasmodium cell biology and immunology is essential to transform malaria into a vaccine-preventable disease.

Open Access

Combating multidrug-resistant Plasmodium falciparum malaria

  • Pages: 2569-2578
  • First Published: 05 June 2017
Combating multidrug-resistant Plasmodium falciparum malaria Issue 16, 2017

Combating the spread of drug-resistant Plasmodium falciparum requires a comprehensive approach. Modern information technology provides the means to detect, enumerate, map and monitor cases of malaria resistance and the foci of transmission. Early detection and treatment of clinical cases, detection of submicroscopic reservoirs and adapted vector control are the three pillars of a successful elimination.

Free Access

Oxidative stress in malaria and artemisinin combination therapy: Pros and Cons

  • Pages: 2579-2591
  • First Published: 03 May 2017
Oxidative stress in malaria and artemisinin combination therapy: Pros and Cons Issue 16, 2017

Malaria is characterized with oxidative stress derived from both the parasite's metabolism and the host immune response. Some antimalarial drugs increase oxidative stress. While oxidative stress can help eliminate parasites, it can also exacerbate the pathology. This article reviews oxidative stress in view of the current artemisinin-based combination therapies in malaria.

Free Access

Unraveling the importance of the malaria parasite helicases

  • Pages: 2592-2603
  • First Published: 13 May 2017
Unraveling the importance of the malaria parasite helicases Issue 16, 2017

Plasmodium falciparum contains nearly 5400 genes and a multistage life cycle in humans and mosquitoes. Helicases are ATP-dependent nucleic acid unwinding enzymes. The P. falciparum genome analysis depicts that it contains some parasite-specific helicases and homologs to most of the human helicases. Here, an overview of P. falciparum helicases and their importance in parasite growth and survival is presented.

Open Access

Proteases as antimalarial targets: strategies for genetic, chemical, and therapeutic validation

  • Pages: 2604-2628
  • First Published: 09 June 2017
Proteases as antimalarial targets: strategies for genetic, chemical, and therapeutic validation Issue 16, 2017

Proteases play a variety of biological functions in the malaria parasite. These include core biological processes such as protein homeostasis and traffic, but also parasite-specific functions (haemoglobin degradation, parasite egress, red blood cell invasion). This review provides an overview about the role of proteases in parasite development and outlines chemical and genetic strategies to validate proteases as therapeutic targets.

Original Articles

Free Access

[Fe–S] cluster assembly in the apicoplast and its indispensability in mosquito stages of the malaria parasite

  • Pages: 2629-2648
  • First Published: 11 July 2017
[Fe–S] cluster assembly in the apicoplast and its indispensability in mosquito stages of the malaria parasite Issue 16, 2017

The sulfur mobilization (SUF) pathway of iron–sulfur [Fe–S] cluster assembly in the apicoplast of the malaria parasite has been delineated in this study. [4Fe–4S] clusters assembled on the SufBC2D complex are transferred to targets via either NfU or SufA. Conditional knockout of SufS, the first enzyme of the pathway, demonstrates its essentiality in sporozoite development in the mosquito, providing support for SUF as a potential intervention site.

Free Access

Lipid interactions modulate the structural and antigenic properties of the C-terminal domain of the malaria antigen merozoite surface protein 2

  • Pages: 2649-2662
  • First Published: 15 June 2017
Lipid interactions modulate the structural and antigenic properties of the C-terminal domain of the malaria antigen merozoite surface protein 2 Issue 16, 2017

MSP2 from the malaria parasite Plasmodium falciparum induces a protective immune response. Tethering the conserved C-terminal region (MSP2172–221) to liposomes induced an antigenic state that was more similar to the parasite antigen. Lipid-conjugated MSP2 may represent a useful vaccine formulation.

Free Access

A widened substrate selectivity filter of eukaryotic formate-nitrite transporters enables high-level lactate conductance

  • Pages: 2663-2673
  • First Published: 21 May 2017
A widened substrate selectivity filter of eukaryotic formate-nitrite transporters enables high-level lactate conductance Issue 16, 2017

Formate-nitrite transporters (FNT) contain a substrate selectivity filter based on a lysine in a hydrophobic environment (Φ/K). It is reminiscent of the aquaporin aromatic/arginine region regarding composition, function, and location within the protein. Eukaryotic FNTs conduct lactate due to a funnel-shaped vestibule and a wide selectivity filter, whereas prokaryotic FNTs select for smaller substrates, mainly formate, nitrite, hydrosulfide, and acetate.

Free Access

Identification and characterization of ARS-like sequences as putative origin(s) of replication in human malaria parasite Plasmodium falciparum

  • Pages: 2674-2695
  • First Published: 23 June 2017
Identification and characterization of ARS-like sequences as putative origin(s) of replication in human malaria parasite Plasmodium falciparum Issue 16, 2017

The eukaryotic genome replicates from multiple sites called origins. The genomic organization of these sites has been elusive in higher eukaryotes as well as in protozoan parasites. Here, we have identified and characterized the origins in Plasmodium falciparum by bioinformatic analysis and an experimental approach. An autocorrelation method was used to search for regions showing marked fluctuation or dips that may contain potential replication initiation sites. Finally the results of autocorrelation were verified experimentally.

Table of Contents

Free Access

Table of Contents

  • Pages: 2696
  • First Published: 21 August 2017